Shares of Biocon surged over 7% in early trade on January 7, following an upgrade from international brokerage Jefferies.
Biocon Share Price
Biocon Share Jumps After Subsidiary Receives U.S.FDA Nod For Posoconazole Tablets
Shares of Biocon rose nearly 3% after the company’s subsidiary Biocon Pharma received approval for its ANDA for Posoconazole delayedrelease tablets from the U.S. FDA.
Biocon Gains On Launch Of Generic Version Of Afinitor In The U.S. Market
Shares of Biocon Ltd. rose 1.45% in intraday trade to Rs 370.06 apiece after the company announced the launch of Everolimus tablets, a generic version of Afinitor in the U.S., thereby expanding its generic formulations portfolio.
Biocon Share Price Target ₹632— ₹642 – Neal Bhai Reports
Biocon Share Price Target ₹632— ₹642 – Neal Bhai Reports
Biocon Share Price Rises After Bengaluru Facility Clears Regulatory Inspection
Gold Silver Reports (GSR) – Biocon Rises After Bengaluru Facility Clears Regulatory Inspection – Shares of the drugmaker rose as much as 2.3 percent to Rs 644.35. – The company said that it received an Establishment Inspection Report (EIR) from the U.S. drug regulator for its manufacturing facility in Bengaluru, according to its stock exchange notification.